This article provides an overview and discussion of the collective maternal, fetal and
neonatal outcome research on women maintained on methadone or buprenorphine during …

This article addresses common questions that clinicians face when treating pregnant women
with opioid dependence. Guidance, based on both research evidence and the collective …

Objectives: The prevalence of opioid use disorder (OUD) during pregnancy is increasing.
Practical recommendations will help providers treat pregnant women with OUD and reduce …

Objective: To evaluate maternal and neonatal safety outcomes for methadone and
buprenorphine in the obstetric population. Data Sources: A literature search of PubMed …

Objectives: To compare maternal characteristics, prenatal care, and newborn outcomes in a
cohort of opioid-dependent pregnant women treated with methadone versus buprenorphine …

Aims To assess the safety of buprenorphine compared with methadone to treat pregnant
women with opioid use disorder. Methods We searched PubMed, Embase and the …

Aims This paper reviews the published literature regarding outcomes following maternal
treatment with buprenorphine in five areas: maternal efficacy, fetal effects, neonatal effects …

Background Chronic medical conditions such as opioid dependence require evidence‐
based treatment recommendations. However, pregnant women are under‐represented in …

Most women using heroin are of reproductive age with major risks for their infants. We
review clinical and experimental data on fetal, neonatal and postnatal complications …

The prevalence of opioid use among pregnant people has been increasing over the past
few decades, with a parallel increase in the rate of neonatal abstinence syndrome. Opioid …